Literature DB >> 22505182

Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease.

Rita De Vito1, Anna Alisi, Andrea Masotti, Sara Ceccarelli, Nadia Panera, Arianna Citti, Michele Salata, Luca Valenti, Ariel E Feldstein, Valerio Nobili.   

Abstract

Concomitantly to the obesity epidemic, nonalcoholic fatty liver disease (NAFLD) has become the leading cause of liver disease in children. NAFLD encompasses a spectrum of histological damage ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), with possible progression to cirrhosis. There is growing evidence that the immune system plays a pivotal role in the initiation and progression to NASH but the cellular nature of the hepatic inflammation is still unknown. The present study includes 34 children with biopsy-proven NAFLD. Liver damage was evaluated by the NAFLD activity score (NAS), and the inflammatory infiltrate was characterized by immunohistochemistry for CD45, CD3 and CD163 which are markers of leukocytes, T cells and activated Kupffer cells/macrophages, respectively. Our results have shown that CD45+ (P<0.0001) and CD163+ (P<0.0001) cells were markedly increased in children with severe histological activity (NAS≥5) compared to children with lower activity (NAS<5), whereas CD3+ cells were significantly lower (P<0.01) in children with severe histological activity. There was a significant association between the numbers of CD45+, CD3+ and CD163+ cells, regarding both the portal tract and liver lobule, and the severity of steatosis, ballooning and fibrosis (P<0.01). These data suggest that the severity and composition of the inflammatory infiltrate correlate with steatosis and the severity of disease in children with NAFLD. Moreover, a decrease in CD3+ cells may be involved in the pathogenesis of liver damage. Future studies should evaluate whether it can predict the progression of liver disease independently of established histological scores.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22505182     DOI: 10.3892/ijmm.2012.965

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  27 in total

1.  Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease.

Authors:  Kathleen E Corey; Uri Kartoun; Hui Zheng; Raymond T Chung; Stanley Y Shaw
Journal:  Am J Gastroenterol       Date:  2016-03-01       Impact factor: 10.864

Review 2.  IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression.

Authors:  Daniel A Giles; Maria E Moreno-Fernandez; Senad Divanovic
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 3.  Biomarkers in nonalcoholic fatty liver disease.

Authors:  Manuela G Neuman; Lawrence B Cohen; Radu M Nanau
Journal:  Can J Gastroenterol Hepatol       Date:  2014-12

4.  Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion.

Authors:  Merlin Airik; Blake McCourt; Tugba Tastemel Ozturk; Amy B Huynh; Xiaoyi Zhang; Justin T Tometich; Rezan Topaloglu; Hasan Ozen; Diclehan Orhan; Kari Nejak-Bowen; Satdarshan P Monga; Timothy W Hand; Fatih Ozaltin; Rannar Airik
Journal:  FASEB J       Date:  2022-02       Impact factor: 5.834

Review 5.  Immune cells and metabolic dysfunction.

Authors:  Ashley Eheim; Dasa Medrikova; Stephan Herzig
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

6.  Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease.

Authors:  Shikha S Sundaram; Ann Halbower; Zhaoxing Pan; Kristen Robbins; Kelley E Capocelli; Jelena Klawitter; Colin T Shearn; Ronald J Sokol
Journal:  J Hepatol       Date:  2016-08-05       Impact factor: 25.083

Review 7.  Apoptosis and necrosis in the liver.

Authors:  Maria Eugenia Guicciardi; Harmeet Malhi; Justin L Mott; Gregory J Gores
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

8.  Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) reduce the expression of toll-like receptor 4 in mice with alcoholic liver disease.

Authors:  Meegun Hong; Seung Woo Kim; Sang Hak Han; Dong Joon Kim; Ki Tae Suk; Yeon Soo Kim; Myong Jo Kim; Moon Young Kim; Soon Koo Baik; Young Lim Ham
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

Review 9.  Drug Trafficking into Macrophages via the Endocytotic Receptor CD163.

Authors:  Jonas Heilskov Graversen; Søren Kragh Moestrup
Journal:  Membranes (Basel)       Date:  2015-06-23

Review 10.  Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis.

Authors:  Luisa Vonghia; Peter Michielsen; Sven Francque
Journal:  Int J Mol Sci       Date:  2013-10-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.